QA: Royalty Pharma plc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001802768_2025_Royalty_Pharma_plc.pdf

Logs

Graph

Absolute values for 0001802768, Royalty Pharma plc

  xvar xval
0 AssetsCurrent 1,802,139,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 16,420,576,000
4 LiabilitiesCurrent 1,253,616,000
5 LiabilitiesNoncurrent 6,626,733,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 236,309,034
9 ResearchAndDevelopmentExpense -10,981,150
10 remainder_Expenses 678,494,771
11 remainder_Revenues 2,256,479,428
12 remainder_NetIncome 89,235,119
13 remainder_ComprehensiveNetIncome -490,889,772
  yvar yval
0 Assets 18,222,715,000
1 Liabilities 7,880,349,000
2 Expenses 903,822,655
3 Revenues 2,256,479,428
4 StockholdersEquity 10,342,366,000
5 NetIncome 1,441,891,892
6 ComprehensiveNetIncome 1,196,447,006
7 BaseVar 14,921,745,487
8 EconomicCapitalRatiobeforeLimitedLiability 1.82
9 EconomicCapitalRatio 2.90

Edgar->Model Mapping

Feature Distribution

Change over Time